PRETOMANID

PRETOMANID was reported 760 times

PRETOMANID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOCARCINOMA GASTRIC RECURRENT 1 0.3333
1 EARLY REPOLARISATION SYNDROME 2 0.2000
2 VENOM POISONING 2 0.0952
3 NEPHROPTOSIS 2 0.0690
4 PULMONARY TUBERCULOMA 1 0.0556
5 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 11 0.0328
6 TROPONIN DECREASED 1 0.0278
7 MALIGNANT URINARY TRACT NEOPLASM 3 0.0252
8 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 1 0.0208
9 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 4 0.0148
10 METASTATIC BRONCHIAL CARCINOMA 2 0.0104
11 MALIGNANT MEDIASTINAL NEOPLASM 1 0.0091
12 BREAST ULCERATION 1 0.0072
13 LIVER SCAN ABNORMAL 1 0.0061
14 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
15 PYELONEPHRITIS CHRONIC 1 0.0053
16 HANGING 1 0.0051
17 CEREBRAL TOXOPLASMOSIS 4 0.0043
18 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
19 OCULAR TOXICITY 4 0.0036
20 NODAL ARRHYTHMIA 3 0.0035
21 HYPOAESTHESIA EYE 2 0.0034
22 ALCOHOL POISONING 9 0.0034
23 RIGHT VENTRICULAR HYPERTROPHY 3 0.0033
24 VESTIBULAR DISORDER 4 0.0033
25 CONGENITAL APLASIA 1 0.0032
26 OESOPHAGEAL CANCER METASTATIC 1 0.0031
27 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
28 DIABETIC HYPERGLYCAEMIC COMA 1 0.0031
29 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
30 HEPATITIS TOXIC 7 0.0027
31 THROMBOTIC CEREBRAL INFARCTION 1 0.0027
32 BRONCHIAL CARCINOMA 2 0.0025
33 CHRONIC HEPATITIS 2 0.0025
34 SQUAMOUS CELL CARCINOMA OF THE TONGUE 1 0.0024
35 TRICHOGLOSSIA 1 0.0024
36 OPTIC NEUROPATHY 5 0.0024
37 PATERNAL EXPOSURE DURING PREGNANCY 2 0.0023
38 PNEUMONIA KLEBSIELLA 4 0.0022
39 PANCREATITIS HAEMORRHAGIC 1 0.0022
40 WOLFF-PARKINSON-WHITE SYNDROME 1 0.0021
41 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
42 CARDIOPULMONARY FAILURE 7 0.0018
43 OPTIC NEURITIS 16 0.0018
44 PHOBIA 2 0.0017
45 BLOOD BILIRUBIN DECREASED 1 0.0016
46 CARDIAC FAILURE ACUTE 10 0.0015
47 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
48 SMALL FIBRE NEUROPATHY 1 0.0014
49 SMALL CELL LUNG CANCER 2 0.0013
50 CRITICAL ILLNESS 1 0.0013
51 GALLBLADDER POLYP 1 0.0013
52 OESOPHAGEAL RUPTURE 1 0.0012
53 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 2 0.0012
54 PARADOXICAL DRUG REACTION 4 0.0011
55 POLYNEUROPATHY 13 0.0011
56 INTUSSUSCEPTION 1 0.0010
57 EMPYEMA 2 0.0010
58 HEPATOTOXICITY 22 0.0010
59 MULTIPLE-DRUG RESISTANCE 3 0.0010
60 PULMONARY TUBERCULOSIS 4 0.0009
61 SOMATIC SYMPTOM DISORDER 1 0.0009
62 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
63 ACARODERMATITIS 1 0.0009
64 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
65 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
66 BILIRUBIN CONJUGATED INCREASED 2 0.0009
67 NEUROPATHY PERIPHERAL 81 0.0009
68 DRUG LEVEL INCREASED 14 0.0008
69 PANCREATITIS CHRONIC 2 0.0008
70 VENTRICULAR ARRHYTHMIA 3 0.0008
71 THROMBOCYTOSIS 3 0.0008
72 AMYLASE INCREASED 3 0.0008
73 HEPATOSPLENOMEGALY 2 0.0008
74 ALCOHOL ABUSE 2 0.0007
75 DEATH NEONATAL 1 0.0007
76 ACUTE ABDOMEN 1 0.0007
77 COCCYDYNIA 1 0.0007
78 SUSPECTED OFF LABEL USE 3 0.0007
79 HIV INFECTION 2 0.0007
80 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
81 DRUG RESISTANCE 16 0.0006
82 MYOCARDIAL ISCHAEMIA 7 0.0006
83 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
84 HYPERTRANSAMINASAEMIA 4 0.0006
85 VASCULAR PSEUDOANEURYSM 1 0.0006
86 MENINGITIS CRYPTOCOCCAL 1 0.0006
87 RETINOPATHY 2 0.0005
88 MYOCARDITIS 6 0.0005
89 PYELONEPHRITIS ACUTE 1 0.0005
90 HYPERAEMIA 1 0.0005
91 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
92 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
93 SPUTUM INCREASED 1 0.0005
94 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
95 MONOPLEGIA 2 0.0005
96 PSEUDOMEMBRANOUS COLITIS 1 0.0004
97 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
98 NEPHROPATHY TOXIC 5 0.0004
99 PAPILLOEDEMA 2 0.0004
100 RENAL COLIC 1 0.0004
101 BLOOD LOSS ANAEMIA 1 0.0004
102 ANAEMIA 84 0.0004
103 LICHENOID KERATOSIS 1 0.0004
104 PNEUMONIA BACTERIAL 4 0.0004
105 NEUROLOGICAL DECOMPENSATION 1 0.0004
106 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
107 CHOLECYSTITIS 5 0.0004
108 HYPOVOLAEMIC SHOCK 2 0.0004
109 PULSE ABNORMAL 1 0.0004
110 HUMERUS FRACTURE 2 0.0004
111 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
112 HEPATITIS C 5 0.0004
113 SINUS BRADYCARDIA 4 0.0004
114 PSYCHIATRIC SYMPTOM 3 0.0004
115 HYPERCALCAEMIA 5 0.0004
116 PLATELET DISORDER 1 0.0004
117 DRUG LEVEL DECREASED 4 0.0004
118 FEMORAL NECK FRACTURE 2 0.0004
119 AORTIC ARTERIOSCLEROSIS 1 0.0004
120 HYPERBILIRUBINAEMIA 4 0.0004
121 RENAL CYST 3 0.0004
122 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
123 INTESTINAL ISCHAEMIA 2 0.0004
124 INTRACRANIAL PRESSURE INCREASED 2 0.0004
125 HAEMOPTYSIS 10 0.0004
126 RESPIRATORY SYMPTOM 1 0.0004
127 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
128 DYSPNOEA AT REST 1 0.0003
129 ABORTION 1 0.0003
130 SPLENOMEGALY 4 0.0003
131 MYELOSUPPRESSION 12 0.0003
132 PRODUCT PRESCRIBING ISSUE 7 0.0003
133 LYMPHOCYTE COUNT INCREASED 1 0.0003
134 PEPTIC ULCER 1 0.0003
135 DEPRESSIVE SYMPTOM 1 0.0003
136 COMMUNICATION DISORDER 1 0.0003
137 LIPASE INCREASED 2 0.0003
138 PROCEDURAL HAEMORRHAGE 1 0.0003
139 SENSORY LOSS 2 0.0002
140 SHOCK HAEMORRHAGIC 2 0.0002
141 PERIPHERAL VENOUS DISEASE 1 0.0002
142 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
143 CARDIAC FAILURE CHRONIC 1 0.0002
144 PRODUCT DISPENSING ISSUE 1 0.0002
145 ABDOMINAL ABSCESS 1 0.0002
146 TRANSAMINASES INCREASED 5 0.0002
147 DRUG-INDUCED LIVER INJURY 7 0.0002
148 IRON DEFICIENCY 1 0.0002
149 BLOOD BILIRUBIN INCREASED 6 0.0002
150 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
151 GASTRITIS EROSIVE 1 0.0002
152 PULSE ABSENT 1 0.0002
153 HEPATOMEGALY 2 0.0002
154 PANCREATIC DISORDER 1 0.0002
155 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
156 TOXIC SKIN ERUPTION 2 0.0002
157 INTENTIONAL SELF-INJURY 4 0.0002
158 NEUTROPHIL COUNT INCREASED 2 0.0002
159 MALABSORPTION 1 0.0002
160 PANCREATITIS 10 0.0002
161 PNEUMOTHORAX 3 0.0002
162 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
163 TREATMENT NONCOMPLIANCE 10 0.0002
164 NECROSIS 1 0.0002
165 CHOLECYSTITIS ACUTE 1 0.0002
166 ACUTE KIDNEY INJURY 27 0.0002
167 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
168 HYPOVOLAEMIA 1 0.0002
169 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
170 COVID-19 PNEUMONIA 2 0.0002
171 PSYCHOTIC DISORDER 5 0.0002
172 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
173 CATARACT OPERATION 1 0.0002
174 HEPATITIS B 1 0.0002
175 LEUKOCYTOSIS 3 0.0002
176 RESPIRATORY DEPRESSION 2 0.0002
177 CARDIAC FAILURE 13 0.0002
178 OLIGURIA 1 0.0002
179 HAEMATEMESIS 4 0.0002
180 ACUTE RESPIRATORY FAILURE 3 0.0002
181 TOXICITY TO VARIOUS AGENTS 26 0.0002
182 TENDON DISORDER 1 0.0002
183 BEDRIDDEN 2 0.0002
184 THROMBOCYTOPENIA 17 0.0002
185 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
186 RESPIRATORY FAILURE 11 0.0002
187 CHOLECYSTITIS CHRONIC 1 0.0001
188 DEATH 126 0.0001
189 RESPIRATION ABNORMAL 1 0.0001
190 AUTOIMMUNE HEPATITIS 1 0.0001
191 CARDIOMYOPATHY 2 0.0001
192 TREATMENT FAILURE 11 0.0001
193 HEPATOCELLULAR CARCINOMA 1 0.0001
194 TROPONIN INCREASED 1 0.0001
195 BRAIN FOG 2 0.0001
196 SUBSTANCE ABUSE 1 0.0001
197 ASPHYXIA 1 0.0001
198 PHOTOSENSITIVITY REACTION 2 0.0001
199 DECREASED APPETITE 28 0.0001
200 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
201 BLOOD UREA INCREASED 2 0.0001
202 HYPOPHAGIA 3 0.0001
203 DEAFNESS 3 0.0001
204 URINE OUTPUT DECREASED 1 0.0001
205 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
206 HEAVY MENSTRUAL BLEEDING 1 0.0001
207 GASTROINTESTINAL CARCINOMA 1 0.0001
208 PATHOGEN RESISTANCE 1 0.0001
209 NEPHROPATHY 1 0.0001
210 PHOTOPHOBIA 2 0.0001
211 ARTERIOSCLEROSIS 1 0.0001
212 ABORTION INDUCED 1 0.0001
213 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
214 PROTEINURIA 2 0.0001
215 VITREOUS FLOATERS 1 0.0001
216 DYSPEPSIA 10 0.0001
217 HYPOAESTHESIA 15 0.0001
218 CORONARY ARTERY DISEASE 3 0.0001
219 VENTRICULAR EXTRASYSTOLES 1 0.0001
220 PETECHIAE 1 0.0001
221 SUDDEN DEATH 1 0.0001
222 EATING DISORDER 2 0.0001
223 VISUAL ACUITY REDUCED 3 0.0001
224 OCULAR DISCOMFORT 1 0.0001
225 EYE INFECTION 1 0.0001
226 HEART RATE IRREGULAR 2 0.0001
227 HEPATIC ENZYME INCREASED 6 0.0001
228 TINNITUS 4 0.0001
229 ELECTROLYTE IMBALANCE 1 0.0001
230 BLOOD IRON DECREASED 1 0.0001
231 PRODUCTIVE COUGH 4 0.0001
232 RESTLESSNESS 3 0.0001
233 CEREBRAL INFARCTION 2 0.0001
234 DERMATITIS ALLERGIC 1 0.0001
235 GASTROINTESTINAL DISORDER 7 0.0001
236 OFF LABEL USE 68 0.0001
237 SUICIDAL IDEATION 7 0.0001
238 ORAL CANDIDIASIS 1 0.0001
239 DRUG INTERACTION 12 0.0001
240 ADVERSE REACTION 1 0.0001
241 ABORTION SPONTANEOUS 3 0.0001
242 QUALITY OF LIFE DECREASED 1 0.0001
243 PULMONARY EMBOLISM 7 0.0001
244 PERIPHERAL COLDNESS 1 0.0001
245 CARDIAC ARREST 6 0.0001
246 NAUSEA 57 0.0001
247 PANCYTOPENIA 4 0.0001
248 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
249 PARAESTHESIA 11 0.0001
250 ANGINA PECTORIS 2 0.0001
251 SEPTIC SHOCK 3 0.0001
252 GASTROENTERITIS 1 0.0001
253 PALPITATIONS 8 0.0001
254 LIVER DISORDER 3 0.0001
255 PULMONARY MASS 1 0.0001
256 LACRIMATION INCREASED 2 0.0001
257 PLATELET COUNT DECREASED 7 0.0001
258 HYPOKALAEMIA 3 0.0001
259 NERVOUS SYSTEM DISORDER 2 0.0001
260 PREMATURE DELIVERY 1 0.0001
261 LACTIC ACIDOSIS 2 0.0001
262 BLOOD POTASSIUM INCREASED 1 0.0001
263 RENAL IMPAIRMENT 5 0.0001
264 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
265 CANDIDA INFECTION 1 0.0001
266 NEUTROPENIA 8 0.0001
267 CIRCULATORY COLLAPSE 1 0.0001
268 EOSINOPHILIA 1 0.0001
269 HYPERKALAEMIA 2 0.0001
270 BRADYCARDIA 3 0.0001
271 HEAD DISCOMFORT 1 0.0001
272 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
273 DRUG ERUPTION 1 0.0001
274 THERAPY INTERRUPTED 4 0.0001
275 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
276 DYSURIA 2 0.0001
277 HEPATIC STEATOSIS 1 0.0001
278 ASTHENIA 20 0.0001
279 EYE PAIN 3 0.0001
280 INTESTINAL OBSTRUCTION 2 0.0001
281 HYPOCALCAEMIA 1 0.0001
282 FRACTURE 1 0.0001
283 GASTRIC ULCER 1 0.0001
284 PULMONARY FIBROSIS 1 0.0001
285 PREGNANCY 1 0.0000
286 BLINDNESS 2 0.0000
287 RIB FRACTURE 1 0.0000
288 PERITONITIS 1 0.0000
289 TREMOR 8 0.0000
290 ABDOMINAL DISCOMFORT 8 0.0000
291 VOMITING 22 0.0000
292 LIVER FUNCTION TEST INCREASED 1 0.0000
293 BLOOD CREATININE INCREASED 3 0.0000
294 MELAENA 1 0.0000
295 SEPSIS 5 0.0000
296 PULMONARY OEDEMA 2 0.0000
297 THERAPY NON-RESPONDER 2 0.0000
298 VISION BLURRED 6 0.0000
299 DYSPHAGIA 4 0.0000
300 BLOOD PRESSURE FLUCTUATION 1 0.0000
301 MENTAL IMPAIRMENT 1 0.0000
302 HYPOGLYCAEMIA 2 0.0000
303 ATRIAL FIBRILLATION 4 0.0000
304 LIVER INJURY 1 0.0000
305 VISUAL IMPAIRMENT 5 0.0000
306 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
307 PNEUMONIA ASPIRATION 1 0.0000
308 LEUKOPENIA 2 0.0000
309 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
310 HEPATITIS 1 0.0000
311 PRURITUS 15 0.0000
312 HAEMOGLOBIN DECREASED 4 0.0000
313 ABDOMINAL PAIN UPPER 8 0.0000
314 SKIN ULCER 1 0.0000
315 ARTHRALGIA 16 0.0000
316 GASTRITIS 1 0.0000
317 FREQUENT BOWEL MOVEMENTS 1 0.0000
318 DRY MOUTH 3 0.0000
319 OEDEMA 2 0.0000
320 PALLOR 1 0.0000
321 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
322 RESPIRATORY ARREST 1 0.0000
323 CONDITION AGGRAVATED 11 0.0000
324 COMPLETED SUICIDE 3 0.0000
325 SKIN EXFOLIATION 3 0.0000
326 RED BLOOD CELL COUNT DECREASED 1 0.0000
327 LIVER FUNCTION TEST ABNORMAL 1 0.0000
328 BLADDER CANCER 2 0.0000
329 ACUTE MYOCARDIAL INFARCTION 1 0.0000
330 OESOPHAGEAL CARCINOMA 1 0.0000
331 RENAL INJURY 1 0.0000
332 PREMATURE BABY 1 0.0000
333 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
334 SUICIDE ATTEMPT 2 0.0000
335 PLEURAL EFFUSION 2 0.0000
336 VERTIGO 2 0.0000
337 FEELING HOT 2 0.0000
338 CARDIAC DISORDER 3 0.0000
339 HYPOTHYROIDISM 1 0.0000
340 RHINORRHOEA 2 0.0000
341 ABDOMINAL PAIN 7 0.0000
342 SYNCOPE 3 0.0000
343 TYPE 2 DIABETES MELLITUS 1 0.0000
344 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
345 NEOPLASM PROGRESSION 1 0.0000
346 SLEEP DISORDER 2 0.0000
347 PNEUMONIA 9 0.0000
348 HYPERGLYCAEMIA 1 0.0000
349 DYSARTHRIA 1 0.0000
350 DYSPNOEA EXERTIONAL 1 0.0000
351 DYSPNOEA 15 0.0000
352 DIABETES MELLITUS 2 0.0000
353 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
354 SEIZURE 3 0.0000
355 DISEASE PROGRESSION 3 0.0000
356 ABNORMAL BEHAVIOUR 1 0.0000
357 WEIGHT DECREASED 7 0.0000
358 PROSTATE CANCER 2 0.0000
359 DIARRHOEA 16 0.0000
360 LUNG NEOPLASM MALIGNANT 1 0.0000
361 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
362 CARDIO-RESPIRATORY ARREST 1 0.0000
363 PRODUCT DOSE OMISSION ISSUE 7 0.0000
364 CEREBROVASCULAR ACCIDENT 4 0.0000
365 HYPOACUSIS 1 0.0000
366 MYOCARDIAL INFARCTION 4 0.0000
367 CONSTIPATION 5 0.0000
368 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
369 DEPRESSION 5 0.0000
370 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
371 CHEST PAIN 4 0.0000
372 HYPERSENSITIVITY 4 0.0000
373 ARRHYTHMIA 1 0.0000
374 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
375 DIZZINESS 10 0.0000
376 BLOOD PRESSURE INCREASED 3 0.0000
377 PERIPHERAL SWELLING 3 0.0000
378 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
379 HEADACHE 12 0.0000
380 HYPERTENSION 4 0.0000
381 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
382 HAEMATOCHEZIA 1 0.0000
383 OXYGEN SATURATION DECREASED 1 0.0000
384 MYALGIA 3 0.0000
385 BACK PAIN 4 0.0000
386 DYSPHONIA 1 0.0000
387 CATARACT 1 0.0000
388 STOMATITIS 1 0.0000
389 OEDEMA PERIPHERAL 2 0.0000
390 DISCOMFORT 1 0.0000
391 EXPOSURE DURING PREGNANCY 1 0.0000
392 RASH 7 0.0000
393 LOSS OF CONSCIOUSNESS 2 0.0000
394 DEEP VEIN THROMBOSIS 1 0.0000
395 BLOOD PRESSURE DECREASED 1 0.0000
396 FALL 5 0.0000
397 INSOMNIA 4 0.0000
398 MALAISE 6 0.0000
399 AGITATION 1 0.0000
400 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
401 INFLUENZA LIKE ILLNESS 1 0.0000
402 DRUG INEFFECTIVE 16 0.0000
403 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
404 COVID-19 2 0.0000
405 TACHYCARDIA 1 0.0000
406 HYPOTENSION 2 0.0000
407 SOMNOLENCE 2 0.0000
408 ABDOMINAL DISTENSION 1 0.0000
409 PYREXIA 3 0.0000
410 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
411 DEHYDRATION 1 0.0000
412 PAIN IN EXTREMITY 2 0.0000
413 HOSPITALISATION 1 0.0000
414 FATIGUE 5 0.0000
415 NASOPHARYNGITIS 1 0.0000
416 PRODUCT USE ISSUE 1 0.0000
417 GAIT DISTURBANCE 1 0.0000
418 WEIGHT INCREASED 1 0.0000
419 COUGH 1 0.0000
420 ANXIETY 1 0.0000